Clinical Trials Directory

Trials / Sponsors / Zenith Epigenetics

Zenith Epigenetics

Industry · 6 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 22021-09-08
Enrolling By InvitationContinuation Protocol for ZEN003694 in Patients Experiencing Clinical Benefit While Enrolled in a ZEN003694 Pr
mCRPC
Phase 1 / Phase 22019-11-12
TerminatedA Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
Triple Negative Breast Cancer
Phase 22019-06-26
CompletedA Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostat
Metastatic Castration-Resistant Prostate Cancer
Phase 1 / Phase 22016-12-01
CompletedA Study of ZEN003694 in Patients With Metastatic Castration-Resistant Prostate Cancer
Metastatic Castration-Resistant Prostate Cancer
Phase 12016-05-01
WithdrawnPhase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refract
Lymphoproliferative Malignancies, Acute Myeloid Leukemia
Phase 12014-10-01